Crystalline composition containing escitalopram oxalate
Details for Australian Patent Application No. 2005218713 (hide)
International Classifications
Event Publications
21 September 2006 PCT application entered the National Phase
PCT publication WO2005/084643 Priority application(s): WO2005/084643
26 October 2006 Amendment Made
The nature of the amendment is: Delete priority details 60/550,909 05 Mar 2004 US 2005221560 Livedo Corporation The nature of the amendment is: Amend the invention title to read Disposable absorbent article
19 November 2009 Application Accepted
Published as AU-B-2005218713
4 March 2010 Opposition Lodged
Sandoz Pty Ltd has lodged an opposition against H. Lundbeck A/S.
3 June 2010 Opposition Proceeding - Application Withdrawn
The opposition by Sandoz Pty Ltd against H. Lundbeck A/S has been withdrawn.
3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
Application withdrawn under section 141(1). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser